Related Experiment Videos
Ex-vivo synergism: a method for optimizing antimicrobial combinations for difficult-to-treat enterococcal
Journal of Chemotherapy (Florence, Italy)
|March 5, 2004
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
OXA-carbapenemases and mutations within PBPs in ST2 carbapenem-resistant A. baumannii: Evaluating the efficacy of cefiderocol and ampicillin-sulbactam combination therapy.
Journal of global antimicrobial resistance·2025
Missed infection prevention and control activities and their predictors: insights from a pre- and post-pandemic study.
The Journal of hospital infection·2024
Real-world corticosteroid use in severe pneumonia: a propensity-score-matched study.
Critical care (London, England)·2021
Balancing evidence and frontline experience in the early phases of the COVID-19 pandemic: current position of the Italian Society of Anti-infective Therapy (SITA) and the Italian Society of Pulmonology (SIP).
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2020
Six-month progression-free survival-related tumor growth rate after upfront chemotherapy as an outcome measure and potential prognostic or stratification variable for patients with unresectable pancreatic adenocarcinoma: an exploratory study cohorts analysis.
Journal of chemotherapy (Florence, Italy)·2026
Pharmacogenomic biomarkers in oncology: evidence, clinical utility, and barriers to implementation.
Journal of chemotherapy (Florence, Italy)·2026
Efficacy and safety of TROP2 antibody-drug conjugate-containing regimen in the patients with HER2 negative metastatic breast cancer and advanced non-small-cell lung cancer.
Journal of chemotherapy (Florence, Italy)·2026
Efficacy and safety of PD-1/PD-L1 inhibitor-combined chemotherapy versus chemotherapy alone in extensive-stage small-cell lung cancer: a meta-analysis.
Journal of chemotherapy (Florence, Italy)·2026
A 1:1:1 propensity score matching design to account for center-specific antimicrobial treatment or prophylaxis in observational studies: the case of the POSACOVID study.
Journal of chemotherapy (Florence, Italy)·2026
The Relationship of CD4+, CD8+, and FOXP3+ Tumor-Infiltrating Lymphocytes and Their Ratios With Clinicopathological Parameters and Tumor Budding in Esophageal Squamous Cell Carcinoma.
International journal of surgical pathology·2026
Reduced Versus Full Lead-In Apixaban or Rivaroxaban in Acute Venous Thromboembolism: A Systematic Review.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·2026
Nanoparticles for fluorescence-guided breast cancer surgery: advances in in vivo preclinical research.
Nanomedicine (London, England)·2026